Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Antidepressants and other psychiatric pharmacotherapy
7 evidence topics · 6 sources
EHDN international guideline: depression, irritability, and anxiety
HDSA physician's guide: pharmacotherapy for depression
German Neurological Society guideline: psychiatric symptoms
Expert-based consensus guidelines on agitation, anxiety, apathy, psychosis, and sleep disorders
“An international committee of 11 multidisciplinary experts proposed a series of statements regarding the description and management of each symptom.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“High-level agreement (≥85% experts strongly agreed or agreed) was reached for 107 of the 110 statements that have been incorporated into the expert-based clinical recommendations presented herein.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Systematic review of pharmacological treatment of neuropsychiatric symptoms
“Fifteen articles qualified for critical evaluation: 10 randomized controlled trials (RCTs) (five placebo-controlled and five cross-over) and five open label studies.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“As a result, convincing evidence that could guide clinical practice is lacking.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote